Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
This study will determine whether the administration of extended-release methylphenidate in treatment-naïve children with Attention Deficit Hyperactivity Disorder (ADHD) affects the frequency of chromosomal abnormalities.
Age
6–12
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Children of both genders, 6-12 years old
Written informed consent by the parent and the patient (over 7)
Diagnosis of ADHD
Age-appropriate cognitive functioning
All patients who had at least one post-baseline cytogenetic assessment in the core study can enter the observation phase.
You may not be if
History of malignant neoplasm
History of seizures (except childhood febrile seizures)
Hyperthyroidism
Concurrent medical condition which may interfere with study
Clareo Health | Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
